Life Science Accelerator Programme: How Cutting-edge Companies are Growing Organically at BioCity NottinghamAmy Cotterill2023-04-19T13:06:42+01:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
NanoSyrinx Joins Life Sciences Incubator in NottinghamAmy Cotterill2023-03-27T16:05:05+01:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Life Sciences Investment Showcase: Connecting Entrepreneurs with Expert Growth FacilitatorsAmy Cotterill2023-04-27T13:12:21+01:00March 23rd, 2023|Accelerator, Investment, News|
Life Sciences Investing: Pioneer Group Reinvests in Biotech Firm NuVisionSteve Jarvis2023-07-24T13:55:07+01:00March 9th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Five Questions With Harry Pickering, Portfolio Director & Head of UK InvestmentSteve Jarvis2023-04-03T14:06:03+01:00February 21st, 2023|Article, Headline Article, Investment|
Pioneer Group Tenant MIP Discovery Secure Funding From Bill & Melinda Gates FoundationSteve Jarvis2023-04-03T14:24:52+01:00February 16th, 2023|Colworth Park, News|
£20m Series A Funding For Two Pioneer Group Accelerator Programme GraduatesVicky Coghlan2023-03-09T15:14:09+00:00February 15th, 2023|Accelerator, Headline Article, News|
Pioneer Group Announce Lead Investment in Selentus ScienceVicky Coghlan2023-02-10T10:37:09+00:00February 7th, 2023|BioCity Nottingham, Investment, News|
AbbVie and Pioneer Group Name NanoSyrinx as the Winner of the 2022 AbbVie UK Golden Ticket ProgrammeGemma Cann2023-07-24T13:59:48+01:00September 27th, 2022|Accelerator, News|
Upperton Pharma Solutions Announces £15m Investment in New FacilitiesGemma Cann2022-06-30T11:25:49+01:00May 23rd, 2022|BioCity Nottingham, News|
